🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey A. Knauf

Cleveland Clinic

ORCID: 0000-0003-4456-8792

Also affiliated with Memorial Sloan Kettering Cancer Center, Cleveland Clinic Lerner College of Medicine, Kettering University, Immune Regulation (United Kingdom)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Endogenous expression of Hras G12V induces developmental defects and neoplasms with copy number imbalances of the oncogene”.

Endogenous expression of Hras G12V induces developmental defects and neoplasms with copy number imbalances of the oncogene

Proceedings of the National Academy of Sciences(2009)10.1073/pnas.0900343106

N/A

0.742DataRank · unranked

140 citations

Norisato Mitsutake, Krista LaPerle, Nagako Akeno, Pat Zanzonico, Valerie A. Longo +9 more

Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors

Molecular Cancer(2022)10.1186/s12943-022-01676-9

N/A

0.510DataRank · unranked

29 citations

Gnana P. Krishnamoorthy, Mahesh Saqcena, Adrián Acuña-Ruíz, Giovanna Revilla, Elisa de Stanchina +6 more

Radioiodine (RAI) in combination with durvalumab for recurrent/metastatic thyroid cancers.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6587

N/A

0.241DataRank · unranked

4 citations

Eric J. Sherman, Anuja Kriplani, Loren S. Michel, Lara Dunn, James Fetten +14 more

Development of animal models to study aggressive thyroid cancers

European Thyroid Journal(2025)10.1530/etj-24-0361

N/A

0.165DataRank · unranked

2 citations

Jeffrey A. Knauf, Shovan Dutta

Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.01.27.635086

N/A

0.165DataRank · unranked

2 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0735

N/A

0DataRank · unranked

109 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

Data from SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies

(2023)10.1158/2159-8290.c.6548987.v1

N/A

0DataRank · unranked

0 citations

Luis J. Leandro‐García, Jesper L.V. Mååg, Vatche Tchekmedyian, Gnana P. Krishnamoorthy, Prasanna P. Tamarapu +13 more

RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs

The Journal of Experimental Medicine(2025)10.1084/jem.20241029

N/A

0DataRank · unranked

9 citations

Anthony Glover, Brian R. Untch, Nickole Sigcha‐Coello, Bin Xu, Dina Vukel +15 more

Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers

Journal of Clinical Investigation(2025)10.1172/jci191781

N/A

0DataRank · unranked

0 citations

Jillian Greenberg, Tianyue Qin, Soo-Yeon Im, Gnana P. Krishnamoorthy, Laura Boucai +12 more

Telomerase reactivation induces progression of mouse Braf V600E -driven thyroid cancers without telomere lengthening

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.24.525280

N/A

0DataRank · unranked

1 citations

Caitlin E.M. Thornton, Bin Xu, Jacob Haase, Gnana P. Krishnamoorthy, Jingzhu Hao +6 more

Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score

The Journal of Clinical Endocrinology & Metabolism(2021)10.1210/clinem/dgab851

N/A

0DataRank · unranked

41 citations

Venkatraman Seshan, Michelle D. Williams, Jeffrey A. Knauf, Mahesh Saqcena, Ronald Ghossein +2 more

Co-inhibition of SMAD and MAPK signaling enhances 124I uptake in BRAF-mutant thyroid cancers

Endocrine Related Cancer(2021)10.1530/erc-21-0017

N/A

0DataRank · unranked

18 citations

Jennifer R. Cracchiolo, Gnana P. Krishnamoorthy, Luis J. Leandro‐García, James Nagarajah, Mahesh Saqcena +11 more

Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2882

N/A

0DataRank · unranked

34 citations

Mahesh Saqcena, Fengshen Kuo, Ravinder K. Grewal, Nicholas D. Socci, Jeffrey A. Knauf +8 more

Telomerase Upregulation Induces Progression of Mouse BrafV600E-Driven Thyroid Cancers and Triggers Nontelomeric Effects

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0144

N/A

0DataRank · unranked

21 citations

Caitlin E.M. Thornton, Bin Xu, Jacob Haase, Gnana P. Krishnamoorthy, Jingzhu Hao +7 more